tarifficli posit rais estim target price
andexxa uptak focu initi expert feedback favor revis estim
ep bigger better rais estim lower target price
note lower estim
merg rival creat scale
expand tool engag
rais ep modestli keep
navig near-term nois favour fundament mid-to-longer-term basi
drugstor trend tracker enhanc intra-quart visibl retail pharmaci
solid capit gener return
today move rate reinforc prefer book valu preserv
imo call transcript specialist call steve schuler
lead la vega latest view lead indic jan capac group busi strong
costa hawkin repeal like limit impact single-famili industri
pharma
sma dmd expert call highlight transcript
fed governor quarl speak
chang nonfarm payrol sep
chang privat payrol sep cs
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
june note rethink sector detail propos implement gic chang provid
histor consist return portfolio characterist new old sector definit chang
extrem disrupt requir modif portfolio process system
offici index track new scheme go forward old scheme histor make comparison difficult
exampl offici perform commun servic blend telecom prior new
broadli defin group post blend new old sector scheme rob portfolio manag abil make
apples-to-appl comparison perform invest characterist
full report compar host characterist revenu earn valuat sharehold return
affect sector time underli data avail upon request
tarifficli posit rais estim target price
new top pick -- tariff one three driver base industri channel check identifi
best posit network switch vendor market increas product list price versu competitor
impos tariff fee high core network product support increas revenu
project factor modest campu switch revenu model revenu contribut
mojo network increas revenu growth rate compound-annual-growth-rate revenu growth estim put us
materi higher consensu back proprietari data center switch market share
model multi-ten data center coverag track data center suppli chain cyruson
digit realti updat project increas target price
attract current level upcom catalyst current trade sale estim
believ discount revenu compound-annual-growth-rate project consensu estim compound-annual-growth-rate
period given updat model increas ep estim
respect upcom catalyst includ cyruson digit realti earn result
assess tariff market revenu share deal volum impact network equip group
investor must-read recent sector primer cloud network fabric prolifer highlight
valuat -- outperform price rate target price base averag forward price-to-earnings
multipl proprietari holt dcf arriv impli potenti upsid
risk risk includ increas technolog competit pressur product refresh cycl time on-going litig
matter
receiv product pleas specifi credit suiss contact email call
andexxa uptak focu initi expert feedback favor revis estim
andexxa uptak focu event month portola ceo chang fda approv andexxa
disappoint uptak bevyxxa agre compani concentr attent andexxa given
grow market opportun front product opportun speak physician clinic
pharmacist use product portola earli suppli program common theme emerg
convers includ broad interest product fairli rapid adopt product clinic practic also
clear question around cost agent broadli adopt still find cost-effect
institut along incorpor insight expert also make modest chang model
note move ep risk includ better
wors expect execut andexxa/bevyxxa
broad interest andexxa especi intracrani bleed expert seen increas critic bleed
factor xa use agent increas addit bleed rate real world exceed seen
pivot trial drug use patient medic comorbid seen
institut use andexxa least hand time low bar use someon intracrani
bleed stock product vari wide institut rang vial mani
keep close expert concern cost andexxa restrict
place one use product similar restrict cheaper product kcentra expert
comment expect institut watch use product close potenti restrict use
futur find cost-effect
ep bigger better rais estim lower target price
ep reflect scale benefit result quarter demonstr lennar abil drive oper effici
cycl integr calatlant larg complet management focus leverag expand scale reduc
construct cost improv capit effici along announc entri strateg agreement
three largest region land develop control total home site look increas option lot
next sever year compani also continu seek way better use new technolog
improv oper well sale market effort come effect cash flow improv
reflect this-a well confid futur growth-mgmt note call consid share repurchas
remain commit reduc leverag
demand commentari in-lin channel check given market fundament includ low unemploy wage
growth persist inventori shortag underli demand remain healthi consist recent realtor
survey management acknowledg slower pace higher-cost west coast msa bay area absorpt sale per
commun per month vs broad-bas strength come region variat
increasingli appar area rel afford see greater demand texa order yoy highlight
sequenti improv organ order growth quarter
revis estim target price maintain outperform rate reflect ep adjust model
estimate goe said target price reflect broader multipl
compress across group maintain outperform rate believ benefit acumen
integr complex transact on-going abil drive overhead leverag
valuat tp ntm bv core hb op fph jv risk inabl execut strateg
initi rise rate
receiv product pleas specifi credit suiss contact email call
note lower estim
strategi intact despit near-term headwind recent host meet ceo karl glassman ir
discuss includ long-term benefit like come revenu margin expans leverag
content gain favor market dynam said also need navig challeng relat under-
perform revenu home furnitur consum product busi well on-going potenti disrupt
given mattress firm uncertain futur encourag path ahead believ uncertainti around
near-term result like leav stock rang bound maintain neutral rate target price
size pressur last year profit furnitur busi come pressur
inflat flat us steel difficult recov given lower cost oversea competit management work cost
cut restructur option look detail upcom quarter meantim
forecast ebit margin furnitur product segment revenu histor
averag reduc ep estim low end guidanc said note limit
inventori within bed channel would mitig impact potenti failur retail leggett financi
well posit withstand event
plenti news look believ leggett well posit deliv annual revenu
growth target specif look content share gain bed led higher-margin comfort coil
unit yoy automot remain cours increas global industri
dynam support widen spread scrap rod price
valuat tp base ntm ebitda estimate vs peer group risk integr recent
acquisit higher inflat
merg rival creat scale
stock after-hour trade recogn excit around cost synergi shorter path
profit see deal fundament address strateg concern believ competit cloud-
nativ offer intensifi challeng hadoop stack cost effect big data storag analysi within
long-term concern remain believ merger creat valu option last resort indic
challeng competit dynam space increas strength cloud-n altern see note hdp
balanc risk/reward downgrad neutral deal help combin compani achiev greater scale
question strateg benefit abil resolv fundament differ hdp
 pure vs hybrid open sourc product focu vs stack go-to-market differ fair differ
creat complementar new combin messag ai edg also see potenti dis-synergi
product roadmap conflict potenti conflict exist partner like
realist synergi target believ annual save combin cost base realist
target repres cog opex save combin compani aim achiev
oper cash flow margin ocf manag indic built revenu synergi model
provid explicit guidanc manag provid framework revenu grow
oper margin compani indic provid precis guidanc closer deal
merger detail all-stock deal expect close hdp sharehold receiv share
 ownership hdp sharehold post-transact
valuat target price impli ev/ci revenu combin compani in-lin premis
infrastructur peer group
receiv product pleas specifi credit suiss contact email call
expand tool engag
competit heat grow competit consum digit wallet come like
squar sq other believ time right expand consum engag strategi help grow
share enhanc monet opportun across platform
offer reward could increas app activ merchant sell good servic shopper
yet app littl afterthought mind consum believ focus app-bas offers-and-
venmo partnership could expand googl trend data suggest venmo/ub partnership yield tangibl result
see potenti venmo becom differenti valuabl platform innov commerc
subscript program costli potenti effect see uniqu opportun membership subscript
capit ampl support engag strategi believ capit constraint manag
commit invest annual grow platform
end agreement posit agreement includ non-compet provis expir
could posit catalyst extent expand strateg option
bottom line market close rtec revis rev/ep rang guidanc
street compani report result cc estimate
rtec highlight delay foundri memori custom believ shortfal driven expans
delay global foundri micron use rough math recogn rtec nich player broad
baromet shortfal rtec could equat much total wfe rtec wfe
wfe bn wfe run-rat still see bottom form albeit growth bottom
question glofo clearli go thru restructur post decis move product tsmc
caus compani rethink capac addit even sell equip secondari market --
believ gloflo like impact equip vendor mu pushout somewhat driven compani
move equip us tw optim fab network confid mu capital-expenditure
guidanc bn y/i unchang albeit would highlight mu wfe guid roughli flat
/ep neg pre rtec revis cs/street q/q rtec
revis ep midpoint cs/street wait revis
ep versu street
memori continu disciplin capital-expenditure adjust continu minim memori oversuppli memori capital-expenditure
peak impli bit growth peak better rel price
price-to-earnings seem full remain lone under-perform rtec lt growth prospect solid see
valuat full cheap specif rtec trade price-to-earnings w/sbc adjust
cut ep premium front end peer
receiv product pleas specifi credit suiss contact email call
sarepta provid biopsi data patient biopsi data patient demonstr micro-dystrophin posit
fiber measur via immunohistochemistri micro-dystrophin express adjust fat/fibrot tissu
western blot higher result first patient micro-dystrophin posit fiber mean
micro-dystrophin express adjust fat/fibrot tissu updat mean ck reduct
june updat
function data impress sarepta help provid patient patient function data updat patient saw
pt improv north ambulatori assess improv baselin consist
function benefit across rang endpoint includ time rise stair collect support
perspect micro-dystrophin function activ patient dose demonstr function improv
expect compani discuss context natur histori expect would expect north score
young y/o ambulatori dmd patient improv significantli lesser degre compar data averag
data set high bar initi investor question gravit toward appar high variabl micro-dystrophin express
across first four patient expect could focal point call tomorrow morn ultim note
therapi result impress albeit small sampl size function benefit across rang endpoint
gener well toler seriou advers event believ collect depth consist data set
high bar competitor cement posit lead gene therapi compani
confer call octob estimate dial-in confer name sarepta updat call
area focu call includ contextu function data durabl treatment interpret caus
varianc dystrophin express durat increas steroid use resolv liver enzym abnorm
rais ep modestli keep
rais ep estim take account highli posit condit oilse crush
margin likelihood compani mtm benefit pull forward faster expect
believ compani rais guidanc agribusi divis take account factor expect
weak edibl oil product sugar divis off-set upsid local price soybean oil ethanol
brazil remain sluggish due oversuppli condit result keep ep estim year unchang
visibl ok great strateg decis earlier year load brazilian bean
 -china trade disput pay give compani good visibl crush margin
januari last year brazilian crop howev uncertainti relat brazilian trucker strike trade
disput made difficult normal lock price next year crop farmer sell better
south especi corn north
navig near-term nois favour fundament mid-to-longer-term basi
manag meet met enbridg inc enb manag today ran gamut topic
perspect near-term stock action somewhat tie increment stock share issu affili
roll-up enbridg energi partner eep enbridg incom fund enf enbridg energi manag eeq
spectra energi partner sep realiti look translat gener malais surround share
near-term yet canadian market overhang remov one exampl usmca trade deal
pipelin view wide crude differenti misunderstood
beyond nois view enb enviabl posit mid-to-longer-term around liquid busi
posit especi replac project first market guid
in-servic date us time seem littl ambiti unless faovur construct weather among factor go
enb way view enb futur network optim program interplay line new incent agreement
new nomin procedur potenti contract collect look favour piper versu shipper
invest thesi enb numer sustain growth platform long durat far-reach increment
impact address bodi work includ spectra spectacular next year enb activ look
revolv around self-help reposit
valuat outperform rate target price obtain target dividend yield
imput bp spread canadian bond yield risk target price rate includ financ
pace develop structur realiti group
receiv product pleas specifi credit suiss contact email call
drugstor trend tracker enhanc intra-quart visibl retail pharmaci
head ep report analyz key metric retail pharmaci includ front-end sale trend chain
drugstor includ volum price/mix promot level base pos data collect nielsen
compani script volum trend report iqvia well commentari industri expert
front-end sale remain soft-cauti optimist store footprint strategi accord nielsen drugstor front-end
sale declin y/i recent four week period end sep sequenti deceler bp
combin jul/aug period repres deterior prior six month averag growth
driver top-line weak declin y/i vs jul/aug price/mix provid off-set increas
repres bp acceler jul/aug period long term outlook front-end sale drugstor channel
remain cautious optimist despit weak traffic trend competit major retail pharmaci includ health
focu optim store footprint drive store traffic clinic
rx volum stabil accord iqvia total adj rx volum growth aug incl flat growth combin
retail channel repres modest improv trend
combin retail channel experienc jul jun respect total rx sale increas chain
store channel aug compar trend jul jun respect repres growth
stabil averag increment posit retail pharmaci name rx growth
recov support latest stabl sale trend
expert commentari posit cs health insur symposium last week industri expert highlight valu
proposit combin pbm/mco model propos health/aetna transact though note
opportun associ pharmaci segment/clin strategi like longer term natur term walgreen
panel highlight benefit unencumb retail pharmaci flexibl partner industri
constitu senior focus primari care medexpress well recent
next- ep report next week forecast ep vs street includ
top-line growth larg driven store acquisit expect gross margin contract bp new pharmaci
network relationship question area includ partnerships/jvs/pilot regulatori environ prefer
network relationship util trend drug price
solid capit gener return
analyz maximum distribut earn compani guid payout sharehold analysi estim
maximum distribut cash distribut earn distribut ep insur coverag deploy base
regulatori allow statutori earn surplu compar estim compani guid pay-out
ratio use cash flow tradit sourc use sinc reflect insur regul
capit return insur entiti
compar financi life insur distribut earn solid payout mid-rang estim averag
distribut earn oper earn distribut earn ratio across coverag
compar averag compani guid pay-out ratio payout mid-rang versu broader financi
averag cs estim pay-out ratio large-cap bank asset manag insur
retail broker life insur reinvest retain cash busi track gener estim
ep growth year-over-year
life sector compel valu distribut earn versu financi still attract pay-out
consid sector distribut earn ratio assum capit reinvest grow busi
life sector appear compel price distribut ep versu averag financi
assum distribut earn ratio insur asset manag retail broker large-cap
bank life sector price compani guid pay-out somewhat higher bank asset manag
materi lower broker said might argu balanc sheet risk life compani
exce broker asset manag discount would reason
company-specif basi outperform-r neutral-r appear best posit distribut
earn compani guid payout two compani possess capital-light busi leav
higher distribut earn ratio lead way guid pay-out ratio support estim
averag distribut earn ratio pois distribut oper earn
guid pay-out well posit divest capital-intens variabl fix annuiti block
consid sale individu life busi outperform-r neutral-r also possess
capital-light busi includ retir servic asset manag though rel capit tie
due plan invest insur and/or intern segment
receiv product pleas specifi credit suiss contact email call
today move rate reinforc prefer book valu preserv
long prefer mreit abil protect book valu challeng environ
offer better risk reward investor today move interest rate anoth remind import book valu
protect risk challeng environ either higher rate wider spread pressur book
valu backdrop continu see offer best risk/reward
interest rate risk light bp move today want highlight rel interest rate risk
mreit acknowledg point data rel stale june mreit might adjust
risk profil
book valu estim book valu averag quarter rise rate
bp wider agenc mb spread bp wider contribut declin book valu
imo call transcript specialist call steve schuler
sept host specialist call subject imo focu critic oct meet
implic refin shipper speaker steve schueler execut chairman maritim capit
marin invest firm steve formerli serv chief commerci offic maersk -- one world largest ship
focu complianc potenti delay octob meet game changer imo expect offici
ban high sulfur fuel on-board vessel without scrubber imo also expect grant author port state
enforc sulfur standard accord imo specialist recent letter flag state request
delay implement contain mislead inform view imo like delay enforc
eager see standard fulli implement futur market day rate ship on-board scrubber price
premium ship scrubber impli market oper sulfur spec chang
enforc entireti januari
on-board one key take-away call endors major ship compani
actual favor chang larg shipper economi scale newer effici vessel lower
oper cost work favor fuel spec chang could forc older smaller vessel busi
could allow larg shipper pass along fuel surcharg cost end user steve expect
european countri also usa china back enforc strong complianc octob meet imo
work individu countri ensur minim cheat
scrubber problem widen spread ulsd- hsfo make scrubber econom compel issu
consid instal take vessel trade month scrubber could cost
instal depend size shipper lose much teu capac instal dispos
sulfur by-product could futur issu instal open loop system open loop system could eventu
ban would requir ship owner instal new close loop system
stock thought conclus next imo meet provid investor confid imo
success implement without delay high complianc level within refin coverag
lever imo upsid high distil yield coke capac usag heavi
sour crude also big winner
receiv product pleas specifi credit suiss contact email call
octob monthli prep pack publish latest version monthli prep pack focu upcom data
point catalyst within coverag univers within bodi note includ number tabl chart
investor found help includ price perform chart updat valuat tabl inform recent
announc ipo
medic meet fda ad comm earn focu us midterm elect loom posit sentiment
around us pharma group remain septemb although wonder octob bring approach us
midterm elect import medic meet month includ easd diabet start
month highlight oct releas phase data co-agonist peptid later
month esmo oncolog highlight import data us merck keytruda head
neck cancer merck kgaa javelin renal bavencio inlyta renal roch
tecentriq abraxan tripl neg breast cancer well acr rheumatolog may
see initi phase data pfizer/lilli tanezumab regeneron/teva fasinumab well galapagos/gilead
filgotinib look insight fda advisori committe meet later month evalu
cardiovascular risk anti-diabet treatment oct expect releas oct brief
document ahead ad second half month also domin
earn kick us oct
pleas let us know would like excel-bas model compani cover large-cap side
cover teva although current restrict smid-
cap side cover aldr alna crv fomx glpg
crude stock built mmbbl well consensu expect mmbbl build averag draw
mmbbl crude stock increas mmbbl mmbbl bearish vs api estim mmbbl
build consensu mmbbl build lower product flat mmbbld yoy crude import
increas mbbld export decreas mbbld cush inventori increas
mmbbl mmbbl last year year averag expect modest crude build
cush given combin heavi padd turnaround activ full restart syncrud project
refin turnaround activ peak domest crude demand remain pressur next week
gasolin stock drew mmbbl bullish vs consensu expect mmbbl build averag
mmbbl build gasolin stock drew mmbbl mmbbl bearish vs api estim mmbbl
draw bullish vs consensu expect mmbbl draw product mbbld net import
decreas mbbld impli gasolin demand yoy vs averag us
gasolin inventori last year level yoy day suppli
distil stock drew mmbbl bullish vs consensu mmbbl draw averag draw
mmbbl distil stock drew mmbbl mmbbl bullish vs api estim mmbbl draw
vs consensu mmbbl draw product decreas mbbld net export mbbld
impli distil demand yoy average distil inventori yoy
yoy day suppli
refin util flat gasolin distil inventori data came better consensu expect
cush built make releas posit refin padd gasolin built mmbbl neg padd
distil drew mmbbl gasolin drew mmbbl cush built posit mid-con refin
cvrr padd gasolin drew mmbl slightli off-set distil build mmbbl still posit
oil-weight ps discount long-term price top pick apc
receiv product pleas specifi credit suiss contact email call
lead la vega latest view lead indic jan capac group busi strong
lead la vega weekli updat lead indic la vega strip macro dashboard latest
view news flow la vega recent initi coverag game caesar best empir
francisco competit summer drive-in traffic notic januari airlin capac almost us
pmi expect
global game held la vega next week host meet expect hear
plenti view strip price weak octob novemb strip book trend impact
shadow suppli growth time new develop resort world econom new convent space
activist propos region game trend game capital-expenditure budget
new develop -- closer consensu think expect convers progress resort world
develop add room northern end la vega strip recent compani affirm
open view consensu view resort world potenti develop event
therefor issu
group busi remain strong nation week industri journal note meet planner across us
difficulti sourc meet venu given strong continu group demand well compet transient
corpor lodg demand -- versu limit growth meet convent suppli view highlight la
vega nativ advantag appeal group segment underscor view weak
outlier demand trend mix return normal level next year
san francisco siphon group demand one lodg reit recent note group book san francisco
trend strongli moscon center renov complet recal one major show rotat san
francisco la vega renov vega compani definit down-play tailwind moscon
renov time note la vega rel room rate critic mass hotel room dine
entertain option nativ advantag
costa hawkin repeal like limit impact single-famili industri
elect day month away taken closer look california proposit potenti impact
single-famili industri come effect base current poll believ unlik prop pass
howev wrong believ impact industri rel limit
prop overview prop initi push forefront one propos solut state
hous shortag prop would repeal costa-hawkin consequ allow local govern adopt rent control
least citi includ lo angel san francisco current form rent control mostli pertain
legaci apart rent repeal costa hawkin would elimin rent control restrict single-famili unit
expos within coverag largest presenc state california
rental portfolio lo angeles/inland empir region pre-exist rent control ordin alreadi exist
effect prop could reflect quickli day would anticip bp declin rental growth
rate southern california portfolio declin growth rate would result approxim downsid
widespread impact unlik besid california state strongli repres democrat permit
form rent control new jersey new york maryland consid single-famili reit neglig presenc
market see prop creat spillov effect toward rent control state
reiter outperform remain confid industri outlook remaind
consid favor suppli demand dynam reiter outperform rate
receiv product pleas specifi credit suiss contact email call
pharma
sma dmd expert call highlight transcript
host call octob dr yaacov anziska associ professor neurolog suni downstat medic
center discuss sma dmd takeaway includ
treatment paradigm leav room improv approv treatment sma spinraza administ
intrathec everi month drug approv decemb dr anziska administ sinc
april patient rang age month year old classifi type drug
clearli benefici administr particularli older type patient challeng older patient often
requir radiolog guidanc inject previou spinal surgeri limit inject window addit
estim older type patient refus treatment burdensom administr procedur
risdiplam appear activ favor differenti spinraza dr anziska believ risdiplam
compar efficaci spinraza type patient set given mechan action expect drug
similar efficaci spinraza type set risdiplam pretti terrif collabor thought initi
sunfish part type data assum risdiplam efficaci compar spinraza expect risdiplam oral
daili administr result becom splice agent choic
chang sma treatment paradigm dr anziska unequivoc expect gene therapi treatment
choic sma patient newli diagnos via newborn screen howev think price reimburs
challeng limit use older type patient expect patient inelig gene therapi use
risdiplam also highlight durabl unknown opin expect
receiv product pleas specifi credit suiss contact email call
headlin price previou day close unless otherwis note
compani mention price oct
labcorp america lh outperform tp
receiv product pleas specifi credit suiss contact email call
